PYRAZOLE DERIVATIVE MODULATOR OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHOD FOR TREATMENT OF NON-SMALL CELL LUNG CANCER

PROBLEM TO BE SOLVED: To provide novel calcium release-activated calcium (CRAC) channel inhibitors.SOLUTION: The present invention provides a compound represented by the following formula, or a tautomer, a prodrug, an N-oxide, a pharmacologically acceptable ester or a pharmacologically acceptable sa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANTHIKIRAN VS VARANSI, GAYATRI SWAROOP MERIKAPUDI, SWAROOP KUMAR V S VAKKALANKA, MEYYAPPAN MUTHUPPALANIAPPAN, SRIKANT VISWANADHA
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide novel calcium release-activated calcium (CRAC) channel inhibitors.SOLUTION: The present invention provides a compound represented by the following formula, or a tautomer, a prodrug, an N-oxide, a pharmacologically acceptable ester or a pharmacologically acceptable salt thereof (where, ring Hy is an optionally substituted, 1,2-diazole ring; ring Ar is a benzene ring, a pyridine ring or the like; L1 and L2 together represent -NH-C(=O)-, -C(=O)NH- or the like; A is not present or represents an alkylene group or the like; Cy is a bicyclic ring selected from a substituted/unsubstituted cycloalkyl group, a substituted/unsubstituted heterocyclyl, a substituted/unsubstituted aryl and a substituted/unsubstituted heteroaryl).SELECTED DRAWING: None 【課題】新規なカルシウム放出依存性カルシウム(CRAC)チャネル阻害剤の提供。【解決手段】式で表される化合物、又はその互変異性体、プロドラッグ、N−オキシド、薬学的に許容されるエステル若しくは薬学的に許容される塩。(環Hyは任意に置換された、1,2−ジアゾール環;環Arはベンゼン環、ピリジン環等;L1及びL2は一緒になって、−NH−C(=O)−、−C(=O)NH−等;Aは存在しないか又はアルキレン基等;Cyは置換/非置換のシクロアルキル基、置換/非置換のヘテロシクリル、置換/非置換のアリール又は置換/非置換のヘテロアリールの二環式環)【選択図】なし